![Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-019-0267-8/MediaObjects/41408_2019_267_Fig1_HTML.png)
Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma | Blood Cancer Journal
Freie Immunglobulin-Leichtketten: Quantitative Analysen und neue Bewertungskriterien bei Dialyse- und Nierenpatienten
![Pipette – Swiss Laboratory Medicine, Nr. 1-2016 | Monoklonale Gammopathien by SULM – Swiss Union of Laboratory Medicine - Issuu Pipette – Swiss Laboratory Medicine, Nr. 1-2016 | Monoklonale Gammopathien by SULM – Swiss Union of Laboratory Medicine - Issuu](https://image.isu.pub/160129141105-15338fd3bbb718728d75fa0b8c467dab/jpg/page_1.jpg)
Pipette – Swiss Laboratory Medicine, Nr. 1-2016 | Monoklonale Gammopathien by SULM – Swiss Union of Laboratory Medicine - Issuu
Die Bestimmung der freien Leichtketten (Freelite TM) und der Immunglobulin- Kappa/Lambda-Subtypen (Hevylite TM) in der Diagnostik
Bestimmung der leichten Kappa- und Lambda-Ketten im Serum ergibt einen Mehrwert in der Diagnostik Plasmazellerkrankungen
![Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10354-022-00912-7/MediaObjects/10354_2022_912_Fig1_HTML.png)